BioWorld

March 8, 2004

View Archived Issues

SuperGen Brings In $34M Via Private Sale Of Stock, Warrants

It seems SuperGen Inc. decided to change its course. Just weeks after disclosing plans to withdraw a proposed stock offering, the cancer drug development company raised $34 million through a stock-and-warrant sale. (BioWorld Today) Read More

FDA Requesting Feedback On Impact Of Medicare Changes

Read More

Shamrock Structures Offering 3-D Protein Structure Services

Read More

Angiotech's Technology Approved In Boston Scientific's Coated Stent

Read More

Other News To Note

Read More

Appointments And Advancements

Read More